急性ST段抬高心肌梗死溶栓结合经皮冠状动脉介入治疗研究进展
李春洁,李景悦,冯超,黄奎,马宇,丛洪良
摘要(Abstract)：
<正>《中国心血管病报告2015》数据显示,心血管疾病死亡占城乡居民总死亡原因的首位,农村为44.60%,城市为42.51%~([1])。未来10年心血管病患病人数仍将快速增长,相关医疗费用给国家和个人带来了巨大的经济负担,已成为重大的公共卫生问题。近年来,冠心病发病率逐年升高且患者趋向年轻化。急性心肌梗死常导致冠心病患者心律失常及心
关键词(KeyWords)： 急性心肌梗死;溶栓;经皮冠状动脉介入治疗
基金项目(Foundation):
作者(Author): 李春洁,李景悦,冯超,黄奎,马宇,丛洪良
参考文献(References)：
- [1]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2015》概要.中国循环杂志,2016,31:624-632.
- [2]李静,李希,胡爽,等.2001-2011年中国东部城市ST段抬高型心肌梗死诊疗趋势.中华心血管病杂志,2016,44(4):303-308.
- [3]M9ckel M,Bocksch W,Strohm S,et al.Facilitated percutaneous coronary intervention(PCI)in patients with acute ST-elevation myocardial infarction:comparison of prehospital tirofiban versus fibrinolysis before direct PCI.Int J Cardiol,2005,103(2):193-200.
- [4]Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention(ASSENT-4 PCI)investigators.Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction(ASSENT-4 PCI):randomised trial.Lancet,2006,367(9510):569-578.
- [5]Ellis SG,Tendera M,de Belder MA,et al.Facilitated PCI in patients with ST-elevation myocardial infarction.N Engl J Med,2008,358(21):2205-2217.
- [6]Armstrong PW,Gershlick AH,Goldstein P,et al.Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.N Engl J Med,2013,368(15):1379-1387.
- [7]盛宇峰,周勇,钱雪松,等.溶栓后时间优化PCI对急性心肌梗死患者远期预后的影响.南京医科大学学报(自然科学版),2014,34(6):766-771.
- [8]D'Souza SP,Mamas MA,Fraser DG,et al.Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction:a metaanalysis.Eur Heart J,2011,32(8):972-982.
- [9]Steg PG,James SK,Atar D,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J,2012,33(20):2569-2619.
- [10]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2015,43(5):380-393.
- [11]国家卫生计生委合理用药专家委员会,中国药师协会.冠心病合理用药指南.中国医学前沿杂志(电子版),2016,8(6):19-108.
- [12]霍勇,傅向华,葛均波,等.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南.中国医学前沿杂志(电子版),2016,8(8):25-41.
- [13]Di Mario C,Dudek D,Piscione F,et al.Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction(CARESS-in-AMI):an open,prospective,randomised,multicentre trial.Lancet,2008,371(9612):559-568.
- [14]Shen LH,Wan F,Shen L,et,al.Pharmacoinvasive therapy for ST elevation myocardial infarction in China:a pilot study.J Thromb Thrombolysis,2012,33(1):101-108.
- [15]Agarwal SK.Pharmacoinvasive therapy for acute myocardial infarction.Catheter Cardiovasc Interv,2011,78(1):72-75.
- [16]张雷明,楚英杰.冠状动脉内溶栓疗法应用的研究进展.中华实用诊断与治疗杂志,2016,30(12):1159-1161.
- [17]Reinstadler SJ,Baum A,Rommel KP,et al.ST segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction.Heart,2015,101(22):1819-1825
- [18]姜海兵,李岚,李秀芬,等.冠状动脉内注射替罗非班或尿激酶治疗急性STEMI患者PCI术中无复流或慢血流的对比研究.临床心血管病杂志,2013,29(10):750-752.
- [19]刘净敏,耿巍,田祥,等.经球囊导管冠状动脉内注射尿激酶原对急性STEMI患者心肌灌注的疗效.临床荟萃,2016,31(11):1192-1196.